Faisal Shaikh, MD
Pulmonary Disease · New York, NYNPI 1669890844
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (44.5%), grants and travel and lodging — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 76.1% of it on its own, with 10 other manufacturers making up the rest. 2025 is the largest year on record at $37,110, more than ten times the $26 reported in 2019. Among pulmonary disease clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 107 payments — averaging $629.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$51K
- Boston Scientific$13K
- Medtronic$1K
- Pulmonx Corporation$917
- Ambu A/s$638
- Olympus America Inc.$192
- plus $506 from 5 others
What the payments were for
- Consulting fees$6381%
- Speaking & faculty fees$9,52014%
- Grants$12,50019%
- Travel & lodging$11,09216%
- Food & beverage$3,6015%
- Education$30,00045%
- Gifts$140%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 86 | $51,282 |
| Boston Scientific | 1 | $12,500 |
| Medtronic | 4 | $1,329 |
| Pulmonx Corporation | 5 | $917 |
| Ambu A/s | 1 | $638 |
| Olympus America Inc. | 3 | $192 |
| Serpex Medical Inc | 1 | $185 |
| Intra-sana Laboratories | 1 | $137 |
| Galvanize Therapeutics, Inc | 3 | $117 |
| Johnson & Johnson | 1 | $43 |
| Olympus Corporation Of The Americas | 1 | $26 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$46,554
- GENERAL - BILIARY DEVICES$12,500
- ION$3,000
- ILLUMISITE$1,178
- ZEPHYR ENDOBRONCHIAL VALVE$856
- CHARTIS CATHETER$264
- ZEPHYR DELIVERY CATHETER$264
- PULMONX CHARTIS TABLET CONSOLE$264
- EVIS EXERA II ULTRASONIC BRONCHOFIBERVIDEOSCOPE$161
- Single Use Guide Sheath Kit$161
- superDimension$139
- Reltone 200 Mg$137
- GLYCATE$137
- Reltone 400 Mg$137
How this compares
$67,364 in reported general payments places this provider in the 95th percentile of 1,115 pulmonary disease providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 38 | $26,168 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 22 | $10,989 |
| Azithromycin | 15 | $38 |
Paid to pharmacies, not to this prescriber.
Other pulmonary disease in New York
- Charles PowellNew York$654K
- Bisher AkilNew York$480K
- Sonali SethiNew York$388K
- Johnathan RaskinNew York$338K
- Monica KraftNew York$247K
- Jamie BessichNew York$226K
- Ronald CrystalNew York$213K
- Michael NiedermanNew York$176K
- Wilfredo TalaveraNew York$145K
- Josanna Rodriguez-LopezNew York$128K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.